Surmodics Inc (NAS:SRDX)
$ 38.46 0.06 (0.16%) Market Cap: 548.71 Mil Enterprise Value: 537.29 Mil PE Ratio: 0 PB Ratio: 4.62 GF Score: 76/100

Surmodics Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 20, 2023 / 02:15PM GMT
Release Date Price: $23.71 (+0.72%)
Mike Matson
Needham & Company, LLC - Analyst

Good morning. Thanks for joining us at the 22nd annual Needham Healthcare Conference. I'm Mike Matson, and I lead the MedTech and diagnostics equity research team at Needham & Company. I'm pleased to introduce Surmodics.

Presenting from Surmodics today, we have CEO, Gary Maharaj; and CFO, Tim Arens. They're going to give a presentation on Surmodics, and then we should have some time for questions. (Conference Instructions)

So with that, I'll turn it over to Gary and Tim.

Tim Arens
Surmodics, Inc. - SVP of Finance & Information Technology & CFO

Thank you, Mike.

Gary Maharaj
Surmodics, Inc. - President & CEO

Thank you, Mike. Thank you all for joining us today. So just to bring your attention to our Safe Harbor statement, given the intrinsic inherent risks and profit probabilities of any of our forward-looking statements.

So let's talk about Surmodics. Surmodics, we're driven. Our mission is really to improve the detection

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot